Clinical study on Lp-PLA2 levels in different types of cognitive impairment
10.3969/j.issn.1672-5921.2011.05.005
- Author:
Chun-Jiang YU
1
Author Information
1. Department of Neurology
- Publication Type:Journal Article
- Keywords:
Alzheimer's disease;
Cognitive disorders;
Dementia, vascular;
Lipoprotein-associated phospholipase A2
- From:
Chinese Journal of Cerebrovascular Diseases
2011;8(5):243-247
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the expression levels of lipoprotein-associated phospholipase A2 (Lp-PLA2) in various types of cognitive impairment. Methods: A total of 212 patients were included in the study. They were divided into mild cognitive impairment (MCI) (n = 46), Alzheimers disease (AD) (n = 58), vascular dementia (VD) (n = 84), and control (n = 24) groups after being screened and evaluated. The concentrations of plasma Lp-PLA2 of patients in each group were measured and compared. The correlation between the Lp-PLA2 level and dementia was analyzed through Cox proportional hazards model. Results: Circled digit oneThe Lp-PLA2 levels in the MCI, AD and VD groups were 45 ± 4 μg/L, 83 ± 15 μg/L, and 112 ± 22 μg/L, respectively, and they were higher than 34 ± 3 μg/L in the control group. The difference was statistically significant (P < 0.05). Circled digit twoThe Lp-PLA2 level was 93 ± 8 μg/L in men, and it was higher than 73 ± 13 μg/L in women in the AD group. The difference was statistically significant (P < 0.05). The Lp-PLA2 level in men was 127 ± 21 μg/L, and it was higher than 97 ± 10 μg/L in women in the VD group. The difference was statistically significant (P < 0.05). Circled digit threeThe Cox proportional hazards model showed that the Lp-PLA2 level was correlated with the high risk of dementia. The correlation of VD was the highest, then AD, and MCI was the lowest. Conclusion: High level of Lp-PLA2 has correlation with mild cognitive impairment, and has gender differences in patients with vascular dementia and Alzheimer's disease, it may be contributive to early diagnosis of cognitive impairment.